Viral load and burden modification following early antiretroviral therapy of primary HIV-1 infection

AIDS

Volumn 13, Issue 7, 1999, Pages 791-796

  Lillo, Flavia B ^c   Ciuffreda, Donatella ^a   Veglia, Fabrizio ^b   Capiluppi, Brunella ^a   Mastrorilli, Elisabetta ^d   Vergani, Barbara ^d   Tambussi, Giuseppe ^a   Lazzarin, Adriano ^a  

^a San Luigi AIDS Center   (Italy)

^b SAN RAFFAELE HOSPITAL   (Italy)

^c IRCCS   (Italy)

^d NONE

Author keywords

HAART; Primary HIV infection; Viral load and burden

Indexed keywords

ANTIRETROVIRUS AGENT; CD4 ANTIGEN; CD8 ANTIGEN; GAG PROTEIN; LAMIVUDINE; RITONAVIR; SAQUINAVIR; VIRUS DNA; VIRUS RNA; ZIDOVUDINE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DRUG TOXICITY; FEMALE; GENE AMPLIFICATION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE COUNT; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; VIREMIA; VIRUS LOAD; VIRUS REPLICATION;

ADULT; ANTI-HIV AGENTS; DNA, VIRAL; DRUG THERAPY, COMBINATION; FEMALE; HIV INFECTIONS; HIV PROTEASE INHIBITORS; HIV-1; HUMANS; MALE; MIDDLE AGED; REVERSE TRANSCRIPTASE INHIBITORS; RITONAVIR; RNA, VIRAL; SAQUINAVIR; VIRAL LOAD; ZIDOVUDINE;

EID: 0001090794     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-199905070-00007     Document Type: Article

References (19)

1. 1. Perelson AS, Essunger P, Cao Y, et al.: Decay characteristics of HIV-1-infected compartments during combination therapy. Nature 1997, 387:188-191.
2. 2. Wong JK, Gunthard HF, Habilir DW, et al.: Reduction of HIV1 in blood and lymph nodes following potent antiretroviral therapy and the virologic correlates of treatment failure. Proc Natl Acad Sci U S A 1997, 94:12574-12579.
3. 3. Chun TW, Carruth L, Finzi D, et al.: Quantification of latent tissue reservoirs and total body viral load in HIV 1 infection. Nature 1997, 387:123-124.
4. 4. Wong JK, Hezareh M, Gunthard HF, et al.: Recovery of replication competent HIV despite prolonged suppression of plasma viremia. Science 1997, 278:1291-1295.
5. 5. Finzi D, Hermankova M, Pierson T, et al.: Identification of a reservoir for HIV1 in patients on highly active antiretroviral therapy. Science 1997, 278:1295-1300.
6. 6. Chun TW, Engel D, Berrey M, et al.: Early establishment of a pool of latently infected, resting CD4 T cells during primary HIV 1 infection. Proc Natl Acad Sci U S A 1998, 95:8869-8873.
7. 7. Ho DD: Toward HIV eradication or remission: the tasks ahead. Science 1998, 280:1866-1867.
8. 8. Kinloch de Loes S, Hirschel BJ, Hoen B, et al.: A controlled trial of zidovudine in primary human immunodeficiency virus infection. N Engl J Med 1995, 333:408-413.
9. 9. Giacomini M, McDermott JL, Giri AA, Martini I, Lillo FB, Varnier OD: A novel and innovative quantitative kinetic software for virological colorimetric assays. J Virol Methods 1998, 73:201-209.
10. 10. Katzenstein TL, Pedersen C, Nielsen C, et al.: Longitudinal serum HIV RNA quantification: correlation to viral phenotype at seroconversion and clinical outcome. AIDS 1996, 10:167-173.
11. 11. Henrard DR, Philips JF, Muenz LR, et al.: Natural history of HIV 1 cell free viremia. JAMA 1995, 274:554-558.
12. 12. Pang S, Shlesinger Y, Daar ES, Moudgil T, Ho DD, Chen ISY: Rapid generation of sequence variation during primary HIV 1 infection. AIDS 1992, 6:453-460.
13. 13. Karlsson AC, Lindbäck S, Gaines H, Sönnerborg A: Characterization of the viral population during primary HIV-1 infection. AIDS 1998, 12:839-847.
14. 14. Poss M, Martin HL, Kreiss JK, et al.: Diversity in virus population from genital secretions and peripheral blood from women recently infected with human immunodeficiency virus type 1. J Virol 1995, 69:8118-8122.
15. 15. Kampinga GA, Simonon A, van de Perre P, Karita E, Msellati P, Goudsmith J: Primary infections with HIV 1 of women and their offspring in Rwanda: findings of heterogeneity at seroconvertion, coinfection and recombination of HIV 1 subtypes A and C. Virology 1997, 227:63-76.
16. 16. Cornelissen M, Mulder-Kampinga G, Veenstra J, et al.: Syncytium inducing (SI) phenotype suppression at seroconversion after intramuscular inoculation of a non-syncytium inducing/SI phenotypically mixed human immunodeficiency virus population. J Virol 1995, 69:1810-1818.
17. 17. Binley JM, Klasse PJ, Cao Y, et al.: Differential regulation of the antibody responses to gag and env proteins of human immunodeficiency virus type 1. J Virol 1997, 71:2799-2809.
18. 18. Sheppard HW, Ascher MS, McRae B, et al.: The initial immune response to HIV and immune system activation determine the outcome of HIV disease. J AIDS 1991, 4:704-712.
19. 19. D'Souza MP, Mathieson BJ: Early phases of HIV type 1 infection. AIDS Res Hum Retroviruses 1996, 12:1-9.